Compare Kyndryl Holdings Inc (KD) vs Liquidia Corporation Common Stock (LQDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kyndryl Holdings Inc vs Liquidia Corporation Common Stock — how do they compare? Kyndryl Holdings Inc trades at $11.78 (market cap $2.57B), while Liquidia Corporation Common Stock trades at $33.75 (market cap $3.04B). The key difference: Liquidia Corporation Common Stock is the larger of the two by market cap, and Liquidia Corporation Common Stock is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kyndryl Holdings Inc for 36 Days and Liquidia Corporation Common Stock for 0 Days on average.
| KD | LQDA | |
|---|---|---|
Market Cap | $2.57B | $3.04B |
Volume | 3,294,342 | 21,111,778 |
Sector | Technology | Health |
52-Week High | $28.92 | $91.03 |
52-Week Low | $10.59 | $22.02 |
Typical Hold Time | 36 Days | 0 Days |
Enterprise Value | $5.39B | $2.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kyndryl (KD) trades at $12.24, up 3.9% on the day, with a neutral technical signal and bearish moving averages. The company reported a return to profitability in 2025 with net income of $252 million, though revenue has declined from prior years. Recent news highlights a strategic focus on AI, including the launch of an innovation lab and an acquisition to bolster healthcare IT services. Positive cash flow generation and a low EV/EBITDA of 3.8 suggest underlying value, but consecutive earnings misses and a high P/E ratio of 31.9 present challenges.
The investment outlook is mixed. A consensus price target of $14.67 implies potential upside, supported by strong operational cash flow and debt reduction. However, risks include declining revenue, thin net margins, and a majority 'Hold' analyst rating. The stock's performance hinges on successful execution of its AI strategy and reversing the top-line contraction seen in recent years.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →
